Showing results (2881-2890 of 8,680) with videos related to

Sort By:
Pageof 868
Bioorganic Chemistry|April 30, 2025
Proteolysis targeting chimera, molecular glue degrader and hydrophobic tag tethering degrader for targeted protein degradation: Mechanisms, strategies and applicationYanchang Pan, Yuanjiang Wang, Shaohua Gou
Bioorganic Chemistry|April 12, 2025
A novel photoactivatable coumarin-based fluorescent "turn-on" probe: Synthesis and applications for H2S detection in living cells and zebrafish modelsPakornsiri Sontisiri, Dusit Promrug, Lalita Srichaimoon, et al.
Bioorganic Chemistry|April 12, 2025
Design, synthesis and in vitro evaluation of non-steroidal anti-inflammatory prodrugs for osteoarthritisIuliia Voitovich, Nancy Ty, Marion Couderc, et al.
Bioorganic Chemistry|April 11, 2025
Design, synthesis and bio-evaluation of 2,5-disubstituted thiazole derivatives for potential treatment of acute myeloid leukemia through targeting CDK9Sumeng Chen, Jindi Huang, Shipeng Zhang, et al.
Bioorganic Chemistry|April 16, 2025
Hybride nanoparticles composed of SN38-modified [12]aneN3 and biotinylated lipids for targeted and synergistic lung Cancer therapyDe-Zhong Xu, Jing-Bo Yang, Xi Zhang, et al.
Bioorganic Chemistry|April 10, 2025
Carvacrol/thymol derivatives as highly selective BuChE inhibitors with anti-inflammatory activities: Discovery and bio-evaluationYuan-Lin Zhang, Hao-Yan Yang, Jie Gou, et al.
Bioorganic Chemistry|April 10, 2025
Inhibition of FLT3-induced signalling in refractory acute myeloid leukaemiaJingmei Yang, Ran Friedman
Bioorganic Chemistry|April 8, 2025
Green synthesis of selenium nanoparticles, and its conjugation with antibacterial proteins for enhancing their antibacterial activityAmany N Mourad, Eman Y T Elariny, Ahmed Shindia, et al.
Bioorganic Chemistry|April 3, 2025
Structure-activity relationship study of navarixin analogues as dual CXCR2 and CCR7 antagonistsAnže Meden, Sandra Claes, Tom Van Loy, et al.
Bioorganic Chemistry|April 6, 2025
Structure-activity relationship explorations of 2-(isoxazol-5-yl)phenyl-3,4-dihydroxybenzoate derivatives to develop potent Wnt/β-catenin pathway inhibitors for colorectal cancer treatmentLi Dong, Tiemei Long, Shanghui Zhang, et al.
Pageof 868